Zdrowie i gospodarka · 11/03/2011
NCI Announces Final Revision of Cancer Therapy Evaluation Program Intellectual Property Option
The National Cancer Institute's Division of Cancer Treatment and Diagnosis is announcing the final revision of the NCI Cancer Therapy Evaluation Program's Intellectual Property Option to Collaborator.